Faculty headshot of Thelma Escobar, PhD

Grant for Escobar Lab Funds AML Research

July 13, 2022 | Categories: Award, Core Faculty, Research | Tagged: , , , , ,

Thelma Escobar, PhD is collaborating with the Doulatov Lab and the Stem Cell Core to study how mutations in the gene NPM1 drive AML onset. Read More

A young man with curly brown hair, a goatee, and a blue button-up shirt stands outdoors in front of modern buildings and leafy trees, looking at the camera with a neutral expression.

Francisco Saavedra Cantillana is a Pew Latin American Fellow

June 30, 2022 | Categories: Award | Tagged: , ,

Francisco Saavedra Cantillana PhD, a Postoc in the Escobar Lab, has been named one of ten 2022 Pew Latin American Fellows in the Biomedical Sciences. Read More

Panel A shows a scatter plot of compounds by sensitivity in AML blasts and LSCs, with blast-specific, LSC-specific, and non-specific drugs colored. Panel B shows a heatmap of inhibition by AML blast-specific compounds in AML blasts and LSCs.

Potential Seen for Tailoring Acute Myeloid Leukemia Treatment

December 3, 2018 | Categories: Announcements, Research | Tagged: , ,

Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies Advances in rapid screening of leukemia cells for drug susceptibility and resistance […] Read More

Four circular cells are shown on a black background, each highlighted in different fluorescent colors: yellow-purple (top left), blue (top right), green (bottom left), and red (bottom right).

Study: Using big data to help fight a deadly cancer

January 12, 2018 | Categories: Research | Tagged: , ,

Researchers built an algorithm to discern which drugs might best combat patients’ individual cases of acute myeloid leukemia. The statistics are grim. For patients fighting an aggressive form of leukemia known as acute myeloid leukemia, or AML, doctors over the last 40 years have usually used a combination of two drugs to fight the disease, but it seldom cures it. Read More